Arrowhead heralded the results as proof of concept that inhibiting the Activin E pathway can improve body composition and ...
In the ongoing study (NCT06700538), Arrowhead’s candidate, called ARO-INHBE, plus Zepbound, doubled weight loss and tripled ...
Arrowhead Pharmaceuticals has surged over 240% in six months, driven by major partnerships and its RNAi drug pipeline. Recent catalysts include a $200M Novartis deal, $300M from Sarepta, and the first ...
Arrowhead Pharmaceuticals, Inc. shares have underperformed despite a lucrative $1.1bn+ licensing deal with Sarepta, providing significant upfront and milestone payments. The Sarepta partnership covers ...
MADISON − The second and final day of the WIAA team state wrestling tournament took place Saturday at UW Field House on the campus of the University of Wisconsin-Madison. Kaukauna (20-0) defeated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback